Developing a non-antibiotic, non-vaccine prevention of C difficile infections focused on pharmacoeconomic profitability
LPOXY Therapeutics has raised $28.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
LPOXY Therapeutics's investors include 5 Horizons Capital.
LPOXY Therapeutics is headquartered in Platte City, United States.
Developing a non-antibiotic, non-vaccine prevention of C difficile infections focused on pharmacoeconomic profitability
LPOXY Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LPOXY Therapeutics — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/lpoxy-therapeutics. Accessed August 13, 2026.
VCBacked. (2025). LPOXY Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/lpoxy-therapeutics
{{cite web |title=LPOXY Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lpoxy-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated